New FDA Approval: Lenvatinib

Editors Note: This is a test post. We're doing this to gather feedback from you. Do you like this format for new FDA approval posts? Do you dislike it? Please let us know in the comments!

If feedback is positive, we will post something similar to this when new drugs are approved by the FDA.

Drug:

Lenvatinib [Lenvima]

Indication:

Locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer

I’m sorry, what in the heck did you just say?

Lenvatinib can be used to treat the vast majority of thyroid cancers (differentiated thyroid cancers account for about 94% of all thyroid carcinomas according to NCCN)--after they have failed radiation therapy.

FDA Approval, ClinicalBrandon DysonMarch 2, 2016lenvatinib, thyroid, thyroid cancer, thyroid disease, sorafenib

Monoclonal Antibodies Made Simple

Monoclonal antibodies (-mabs) are a common source of confusion for pharmacy students. They have long, hard-to-pronounce names that all look and sound alike. It's impossible to tell them apart, let alone keep track of where they're used therapeutically.

Well that ends today, you smarty pants tl;dr pharmacy reader, you. Today we're going to show you how to make sense of the entangled maze of -mabs. We're going to show you that there is actually a system to how monoclonal antibodies are named.

Why bother? Because you can tell most of what you need to know about a monoclonal antibody just by the name. You can learn a few simple rules that apply everywhere instead of crowding your brain memorizing endless details that you'll eventually forget after the test.

You can perform better on tests while spending less time studying and still remember the information.

Not to mention, -mabs are the future. They aren't going anywhere. You are going to see more and more of them because they're effective (both clinically and at making money for Genzyme shareholders).

Clinical, Pharmacy School, Practice, ResidencyBrandon DysonMarch 1, 2016Monoclonal Antibodies, mabs, infusion reaction, NAPLEX, monoclonal antibodies made simple, monoclonal antibody guide, monoclonal antibody clinical pearls, monoclonal antibody nomenclature